With software and drugs becoming increasingly intertwined, the US Food and Drug Administration is marshaling its expertise to make policy decisions and help application assessors.
The agency has established a working group on digital health that will address policy issues related to software that is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?